Evogene Market Cap

Evogene has a market cap or net worth of 30.71 million as of April 1, 2025. Its market cap has decreased by -81.07% in one year.

Market Cap

30.71M

Enterprise Value

43.39M

Revenue

31.00M

Ranking

n/a

PE Ratio

n/a

Stock Price

478.00

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 30.71M, a decrease of -72.86%. That is a compound annual growth rate of -7.19%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	30.71M	-35.15%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	549.28M	305.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	65.58B
Danel (Adir Yeoshua)	2.20B
Kamada	1.41B
Bait Bakfar	960.19M
Novolog (Pharm-Up 1966)	813.77M
Ilex Medical	701.99M
BrainsWay	637.11M
SofWave Medical	564.43M

Market Cap Rankings